Latency-associated peptide identifies therapeutically resistant muscle-invasive bladder cancer with poor prognosis.
Ye R, Zeng H, Liu Z, Jin K, Liu C, Yan S, Yu Y, You R, Zhang H, Chang Y, Wang Y, Liu L, Zhu Y, Xu J, Xu L, Wang Z.
Ye R, et al. Among authors: zhang h.
Cancer Immunol Immunother. 2022 Feb;71(2):301-310. doi: 10.1007/s00262-021-02987-4. Epub 2021 Jun 21.
Cancer Immunol Immunother. 2022.
PMID: 34152439
Free PMC article.